Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ureteric bud epithelium: morphogenesis and roles in metanephric kidney patterning.

Molecular reproduction and development·2015
Same author

Determination of UCP1 expression in subcutaneous and perirenal adipose tissues of patients with hypertension.

Endocrine·2015
Same author

Contrast-enhanced ultrasonography in differential diagnosis of benign and malignant ovarian tumors.

PloS one·2015
Same author

Identification and validation of gene module associated with lung cancer through coexpression network analysis.

Gene·2015
Same author

Cortisone and hydrocortisone inhibit human Kv1.3 activity in a non-genomic manner.

Naunyn-Schmiedeberg's archives of pharmacology·2015
Same author

Efficacy of Chinese eye exercises on reducing accommodative lag in school-aged children: a randomized controlled trial.

PloS one·2015

Related Experiment Video

Updated: Jan 2, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.8K

Nano-Inspired Technologies for Peptide Delivery.

Obdulia Covarrubias-Zambrano1, Jing Yu1,2, Stefan H Bossmann1

  • 1Department of Chemistry, Kansas State University, 419 CBC Building, Manhattan, KS 66506-0401, United States.

Current Protein & Peptide Science
|December 4, 2019
PubMed
Summary
This summary is machine-generated.

Nano-inspired technologies enhance therapeutic peptide delivery, reducing dosages and toxicity. Various nanoplatforms are being explored for improved systemic treatments, though a leading system has yet to emerge.

Keywords:
Peptide drugimmunogenicitynanodeliveryphysiological barrierstherapeutic peptidestoxicity.

More Related Videos

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

17.6K
Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains
11:24

Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains

Published on: March 25, 2015

10.4K

Related Experiment Videos

Last Updated: Jan 2, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.8K
Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

17.6K
Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains
11:24

Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains

Published on: March 25, 2015

10.4K

Area of Science:

  • Biotechnology and Nanomedicine
  • Drug Delivery Systems
  • Therapeutic Peptides

Background:

  • Therapeutic peptides offer promising pharmacological profiles and cost-effective manufacturing for disease treatment.
  • Nanodelivery systems can significantly reduce required peptide dosages, thereby minimizing toxicity and immunogenicity compared to systemic delivery.
  • Combining peptides with nanoparticles or small molecules enables systemic treatment strategies beyond single-target approaches.

Purpose of the Study:

  • To review state-of-the-art nanosized delivery systems for therapeutic peptides and antibodies.
  • To discuss the biochemical and biophysical principles underlying these nanodelivery systems.
  • To highlight the current challenges and ongoing competition among different nanoplatforms.

Main Methods:

  • Review of current literature on nanodelivery systems for therapeutic peptides and antibodies.
  • Analysis of biochemical and biophysical foundations of various nanoplatforms.
  • Comparative assessment of different nanocarrier types, including liposomes, hydrogels, polymers, silica nanospheres, and nanosponges.

Main Results:

  • Nanosized delivery systems show significant potential for enhancing therapeutic peptide efficacy and safety.
  • Diverse nanoplatforms, including liposomes, hydrogels, polymers, silica nanospheres, and nanosponges, are under investigation.
  • No single nanoplatform has definitively emerged as superior for therapeutic peptide delivery.

Conclusions:

  • Nano-inspired technologies present a powerful approach for advancing therapeutic peptide and antibody delivery.
  • Continued research into the biochemical and biophysical aspects of nanodelivery systems is crucial.
  • The field is characterized by active competition among various nanoplatforms, indicating a dynamic and evolving landscape in nanomedicine.